[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100090982":3},{"organization":4,"armGroups":7,"interventions":28,"overallOfficials":46,"centralContacts":39,"locations":50,"responsibleParty":253,"collaborators":39,"id":255,"slug":256,"hasResults":257,"nctId":258,"briefTitle":259,"officialTitle":260,"acronym":39,"eligibilityCriteria":261,"healthyVolunteers":262,"sex":263,"minAge":264,"maxAge":265,"enrollmentInfo":266,"targetDuration":39,"studyType":269,"phases":270,"briefSummary":272,"conditions":273,"keywords":275,"overallStatus":282,"whyStopped":39,"lastUpdateSubmitDate":283,"lastUpdatePostDateStruct":284,"startDateStruct":287,"completionDateStruct":39,"leadSponsor":289,"locationsCount":290},{"fullName":5,"class":6},"Novartis","INDUSTRY",[8,14,20,24],{"label":9,"type":10,"description":11,"interventionNames":12},"1","EXPERIMENTAL","Active terbinafine hydrochloride (HCl) 10 % Nail Solution for Onychomycosis (NSO) applied once daily for 48 weeks",[13],"Drug: terbinafine",{"label":15,"type":16,"description":17,"interventionNames":18},"2","PLACEBO_COMPARATOR","vehicle (placebo) applied once daily for 48 weeks",[19],"Drug: Placebo",{"label":21,"type":10,"description":22,"interventionNames":23},"3","Active terbinafine hydrochloride (HCl) 10 % Nail Solution for Onychomycosis (NSO) applied once daily for 24 weeks",[13],{"label":25,"type":16,"description":26,"interventionNames":27},"4","vehicle (placebo) applied once daily for 24 weeks",[19],[29,36,40,44],{"type":30,"name":31,"description":32,"armGroupLabels":33,"otherNames":34},"DRUG","terbinafine","Active terbinafine hydrochloride (HCl) 10 % Nail Solution for Onychomycosis (NSO) once daily for 48 weeks",[9],[35],"Lamisil",{"type":30,"name":37,"description":17,"armGroupLabels":38,"otherNames":39},"Placebo",[15],null,{"type":30,"name":31,"description":41,"armGroupLabels":42,"otherNames":43},"Active terbinafine hydrochloride (HCl) 10 % Nail Solution for Onychomycosis (NSO) once daily for 24 weeks",[21],[35],{"type":30,"name":37,"description":26,"armGroupLabels":45,"otherNames":39},[25],[47],{"name":48,"affiliation":48,"role":49},"Novartis Pharmaceuticals","STUDY_DIRECTOR",[51,64,74,84,94,104,114,124,134,143,153,163,172,182,191,201,211,220,226,235,245,250],{"facility":52,"status":39,"city":53,"state":54,"zip":55,"country":56,"countryCode":57,"cosmosGeoPoint":58,"geoPoint":63,"contacts":39},"Dr. Boni Elewski","Birmingham","Alabama","35233","United States","US",{"type":59,"coordinates":60},"Point",[61,62],-86.80249,33.52066,{"lat":62,"lon":61},{"facility":65,"status":39,"city":66,"state":67,"zip":68,"country":56,"countryCode":57,"cosmosGeoPoint":69,"geoPoint":73,"contacts":39},"Dr. Stacy Smith","San Diego","California","92123",{"type":59,"coordinates":70},[71,72],-117.16472,32.71571,{"lat":72,"lon":71},{"facility":75,"status":39,"city":76,"state":77,"zip":78,"country":56,"countryCode":57,"cosmosGeoPoint":79,"geoPoint":83,"contacts":39},"Dr. James Swinehart","Denver","Colorado","80210",{"type":59,"coordinates":80},[81,82],-104.9847,39.73915,{"lat":82,"lon":81},{"facility":85,"status":39,"city":86,"state":87,"zip":88,"country":56,"countryCode":57,"cosmosGeoPoint":89,"geoPoint":93,"contacts":39},"Dr. David G. Armstrong","North Chicago","Illinois","60064",{"type":59,"coordinates":90},[91,92],-87.84118,42.32558,{"lat":92,"lon":91},{"facility":95,"status":39,"city":96,"state":97,"zip":98,"country":56,"countryCode":57,"cosmosGeoPoint":99,"geoPoint":103,"contacts":39},"Dr. Kevin Terry","Lutherville","Maryland","21093",{"type":59,"coordinates":100},[101,102],-76.62608,39.42122,{"lat":102,"lon":101},{"facility":105,"status":39,"city":106,"state":107,"zip":108,"country":56,"countryCode":57,"cosmosGeoPoint":109,"geoPoint":113,"contacts":39},"Dr. Anthony Puopolo","Milford","Massachusetts","01757",{"type":59,"coordinates":110},[111,112],-71.51617,42.13982,{"lat":112,"lon":111},{"facility":115,"status":39,"city":116,"state":117,"zip":118,"country":56,"countryCode":57,"cosmosGeoPoint":119,"geoPoint":123,"contacts":39},"Dr. John Fenyk","Chaska","Minnesota","55318",{"type":59,"coordinates":120},[121,122],-93.60218,44.78941,{"lat":122,"lon":121},{"facility":125,"status":39,"city":126,"state":127,"zip":128,"country":56,"countryCode":57,"cosmosGeoPoint":129,"geoPoint":133,"contacts":39},"Dr. Joel Schlessinger","Omaha","Nebraska","68144",{"type":59,"coordinates":130},[131,132],-95.94043,41.25626,{"lat":132,"lon":131},{"facility":135,"status":39,"city":136,"state":136,"zip":137,"country":56,"countryCode":57,"cosmosGeoPoint":138,"geoPoint":142,"contacts":39},"Dr. AnneMarie Uliasz","New York","10029",{"type":59,"coordinates":139},[140,141],-74.00597,40.71427,{"lat":141,"lon":140},{"facility":144,"status":39,"city":145,"state":146,"zip":147,"country":56,"countryCode":57,"cosmosGeoPoint":148,"geoPoint":152,"contacts":39},"Dr. Willard Niemi","Raleigh","North Carolina","27615",{"type":59,"coordinates":149},[150,151],-78.63861,35.7721,{"lat":151,"lon":150},{"facility":154,"status":39,"city":155,"state":156,"zip":157,"country":56,"countryCode":57,"cosmosGeoPoint":158,"geoPoint":162,"contacts":39},"Dr. Diane Baker","Lake Oswego","Oregon","97035",{"type":59,"coordinates":159},[160,161],-122.67065,45.42067,{"lat":161,"lon":160},{"facility":164,"status":39,"city":165,"state":156,"zip":166,"country":56,"countryCode":57,"cosmosGeoPoint":167,"geoPoint":171,"contacts":39},"Dr. John Barnes","Portland","97205",{"type":59,"coordinates":168},[169,170],-122.67621,45.52345,{"lat":170,"lon":169},{"facility":173,"status":39,"city":174,"state":175,"zip":176,"country":56,"countryCode":57,"cosmosGeoPoint":177,"geoPoint":181,"contacts":39},"Dr. Harry Penny","Altoona","Pennsylvania","16602",{"type":59,"coordinates":178},[179,180],-78.39474,40.51868,{"lat":180,"lon":179},{"facility":183,"status":39,"city":184,"state":175,"zip":185,"country":56,"countryCode":57,"cosmosGeoPoint":186,"geoPoint":190,"contacts":39},"Dr. Lawrence Parish","Philadelphia","19103",{"type":59,"coordinates":187},[188,189],-75.16362,39.95238,{"lat":189,"lon":188},{"facility":192,"status":39,"city":193,"state":194,"zip":195,"country":56,"countryCode":57,"cosmosGeoPoint":196,"geoPoint":200,"contacts":39},"Dr. Cynthia Strout","Mt. Pleasant","South Carolina","29464",{"type":59,"coordinates":197},[198,199],-79.86259,32.79407,{"lat":199,"lon":198},{"facility":202,"status":39,"city":203,"state":204,"zip":205,"country":56,"countryCode":57,"cosmosGeoPoint":206,"geoPoint":210,"contacts":39},"Dr. Teresa Coats","Austin","Texas","78705",{"type":59,"coordinates":207},[208,209],-97.74306,30.26715,{"lat":209,"lon":208},{"facility":212,"status":39,"city":213,"state":204,"zip":214,"country":56,"countryCode":57,"cosmosGeoPoint":215,"geoPoint":219,"contacts":39},"Dr. Scott J. Ashton","Dallas","75243",{"type":59,"coordinates":216},[217,218],-96.80667,32.78306,{"lat":218,"lon":217},{"facility":221,"status":39,"city":213,"state":204,"zip":222,"country":56,"countryCode":57,"cosmosGeoPoint":223,"geoPoint":225,"contacts":39},"Dr. Amit Pandya","75390-8802",{"type":59,"coordinates":224},[217,218],{"lat":218,"lon":217},{"facility":227,"status":39,"city":228,"state":204,"zip":229,"country":56,"countryCode":57,"cosmosGeoPoint":230,"geoPoint":234,"contacts":39},"Dr. Lawrence Harkless","San Antonio","78207",{"type":59,"coordinates":231},[232,233],-98.49363,29.42412,{"lat":233,"lon":232},{"facility":236,"status":39,"city":237,"state":238,"zip":239,"country":56,"countryCode":57,"cosmosGeoPoint":240,"geoPoint":244,"contacts":39},"Dr. Robert Shouey","Harrisonburg","Virginia","22801",{"type":59,"coordinates":241},[242,243],-78.86892,38.44957,{"lat":243,"lon":242},{"facility":246,"status":39,"city":247,"state":39,"zip":39,"country":248,"countryCode":249,"cosmosGeoPoint":39,"geoPoint":39,"contacts":39},"Novartis Investigative Site","Various Cities","Canada","CA",{"facility":246,"status":39,"city":247,"state":39,"zip":39,"country":251,"countryCode":252,"cosmosGeoPoint":39,"geoPoint":39,"contacts":39},"Iceland","IS",{"type":254,"investigatorFullName":39,"investigatorTitle":39,"investigatorAffiliation":39,"oldNameTitle":39,"oldOrganization":39},"SPONSOR","100090982","phase-3-efficacy-safety-and-tolerability-of-topical-terbinafine-in-patients-with-mild-to-moderate-toenail-fungus-of-the-big-toenail-100090982",true,"NCT00443898","Efficacy, Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail","A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Topical Terbinafine Hydrogen Chloride (HCl) Formulation for 24 or 48 Weeks of Treatment in Patients With Mild to Moderate Toenail Onychomycosis","Inclusion Criteria:\n\n* Male and females 12 - 75 years of age\n* Fungal toenail infection of one or both of the large (great) toenails\n* The nail infection must be due to a dermatophyte, (mixed infections \\[dermatophyte and non-dermatophyte\\] are not allowed)\n\nExclusion Criteria:\n\n* Target foot must not have severe plantar (moccasin) tinea pedis that would require systemic therapy. Mild to moderate tinea pedis (athlete's foot) infection should be treated with terbinifine prior to baseline or at any time during the trial. Other topical treatments for athlete's foot may be recommended at the discretion of the investigator.\n* Subjects must not have abnormalities of the nail that could prevent a normal appearing nail if clearing of infection is achieved\n* No administration of systemic antifungal medications within 6 months prior to screening visit\n* No application of prescription topical antifungal medications for toenail fungus within 3 months or other commercially available topical medications for toenail fungus applied directly to the toenails within 1 month prior to screening visit\n* No professional pedicures or application of any nail polish product or nail cosmetic to the toenails after the screening visit\n* Known pregnancy or lactation at time of enrollment\n\nOther protocol-defined inclusion\u002Fexclusion criteria may apply",false,"ALL","12 Years","75 Years",{"count":267,"type":268},518,"ACTUAL","INTERVENTIONAL",[271],"PHASE3","This study is designed to assess the efficacy, safety and tolerability of a topical formulation of terbinafine solution applied daily in patients with toenail fungus. This trial will study patients with mild to moderate toenail fungus disease of the big toenail and their responses to two treatment durations, 24 or 48 weeks.",[274],"Onychomycosis",[276,274,277,278,279,280,281],"Toenail fungus","Nail fungus","Toenail fungal infection","Tinea unguium","Dermatophytes","Foot dermatoses","COMPLETED","2012-05-01",{"date":285,"type":286},"2012-05-03","ESTIMATED",{"date":288,"type":39},"2006-12",{"name":48,"class":6},22]